The first two drugs showing promise in slowing the progression of geographic atrophy are poised for FDA approval. Will this signal a new era in patient care?
The February supplement from the USC Roski Eye Institute can be found here: 2022 Annual Report.
DETECT THE HIDDEN DANGER OF
THYROID EYE DISEASE (TED)
© 2022 Horizon Therapeutics plc DA-UNBR-US-01273 12/22